Original Article

Evaluation of Serum Level of Interleukin-1 in Patients Suffering from Acute Coronary Syndrome, Admitted to the CCU Ward of Amir-Almomenin Hospital of Zahedan

Abstract

Background: Atherosclerosis is a disease in which the particles of fat builds up in the blood vessel’s walls. This build up leads to blood flow blockage or can cause the arteries to narrow, but until the stenosis of the vessel is not more than 70 percent, there won’t be any obvious symptoms. Symptoms are dependent on the location of the stenosis that can bring about diseases such as, Unstable Angina (UA), Myocardial Infarction with Q Wave (MIQW) and Non Q Wave (NMIQW). The most common causes of death in most developed countries is Coronary Artery Disease (CAD), and since the inflammatory factors are one of the causes of these diseases, we decided to evaluate the level of the Interleukin-1 (IL-1) in patients with acute coronary syndrome.
Methods: 90 patients, suffering from the acute coronary syndrome were selected, which were previously diagnosed and referred to a cardiologist in the Imam Ali Ebneh hospital’s cardiac ward, in 2011. Five ml of periphery blood was obtained from each patient, after 24 hours of hospitalization. Using the ELISA method, the level of interleukin-1 was measured in the three groups of patients, each with symptoms of UA, MIQW and MINQW.
Results: Our findings, showed the highest level of interleukin-1 in the MIQW patients, with the average of 46.55 pg/ml and, the lowest level in the MINQW patients, with the average of 28.17 pg/ ml. Moreover, the average level of IL-1 in the patient’s serum with UA, is determined equal to 31.28 pg/ml. Although, there was no significant correlations between the type of MI development and UA, there was a significant correlation between the level of IL-1 and the type of MI development.
Conclusion: Despite the fact, that the level of IL-1 was higher than normal in all the group types, and no significant correlation between the type of MI development and UA was found, there was statistically a significant correlation between the types of MI development and the level of IL-1.

1. Tunstall-pedoe H, Kulasmaa K, Amouyel P, Arveiler D, Rajakangas AM, Pajak A. Myocardial infarction and coronary deaths in the World Health Organization MONICA Project. Registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents. Circulation. 1994;90(1):583-612.
2. Libby P, Bonow RO. Approch to the patient with chest pain. In: Braunwald E, Zipes DP,Libby P,editors. textbook of cardiovascular medicine. 7th ed. Philadelphia: Saunders; 2005: 1132-4.
3. Ross R. The pathogenesis of atherosclerosis--an update. N Engl J Med. 1986;314(8):488-500.
4. Foreman RD. Mechanisms of cardiac pain. Annu Rev Physiol. 1999;61(1):143-67.
5. Biasucci LM, Liuzzo G, Fantuzzi G, Caligiuri G, Rebuzzi AG, Ginnetti F, et al. Increasing levels of interleukin (IL)-1Ra and IL-6 during the first 2 days of hospitalization in unstable angina are associated with increased risk of in-hospital coronary events. Circulation. 1999;99(16):2079-84.
6. Worthley SG, Osende JI, Helft G, Badimon JJ, Fuster V. Coronary artery disease: pathogenesis and acute coronary syndromes. Mt Sinai J Med. 2001;68(3):167-81.
7. Wagner DD. New links between inflammation and thrombosis. Arterioscler Thromb Vasc Biol. 2005;25(7):1321-4.
8. Kudenchuk PJ, Maynard C, Martin JS, Wirkus M, Weaver WD. Comparison of presentation, treatment, and outcome of acute myocardial infarction in men versus women (the Myocardial Infarction Triage and Intervention Registry). Am J Cardiol. 1996;78(1):9-14.
9. Zucker DR, Griffith JL, Beshansky JR, Selker HP. Presentations of acute myocardial infarction in men and women. J Gen Intern Med. 1997;12(2):79-87.
10. Hansson GK, Libby P. The immune response in atherosclerosis: a double-edged sword. Nature Reviews Immunology. 2006;6(7):508-19.
11. Björkbacka H, Kunjathoor VV, Moore KJ, Koehn S, Ordija CM, Lee MA, et al. Reduced atherosclerosis in MyD88-null mice links elevated serum cholesterol levels to activation of innate immunity signaling pathways. Nat Med. 2004;10(4):416-21.
12. Campbell TC, Parpia B, Chen J. Diet, lifestyle, and the etiology of coronary artery disease: the Cornell China study. Am J Cardiol. 1998;82(10b):18t-21t.
13. Mangge H, Hubmann H, Pilz S, Schauenstein K, Renner W, März W. Beyond cholesterol- -inflammatory cytokines, the key mediators in atherosclerosis. Clin Chem Lab Med. 2004;42(5):467-74.
14. Bhakdi S, Torzewski M, Paprotka K, Schmitt S, Barsoom H, Suriyaphol P, et al. Possible protective role for C-reactive protein in atherogenesis: complement activation by modified lipoproteins halts before detrimental terminal sequence. Circulation. 2004;109(15):1870-6
15. Burger-Kentischer A, Goebel H, Seiler R, Fraedrich G, Schaefer HE, Dimmeler S, et al. Expression of Macrophage Migration Inhibitory Factor in Different Stages of Human Atherosclerosis. Circulation. 2002;105(13):1561-6.
16. Robertson AK, Hansson GK. T cells in atherogenesis: for better or for worse? Arterioscler Thromb Vasc Biol. 2006;26(11):2421-32.
17. Dinarello CA. The role of the interleukin-1-receptor antagonist in blocking inflammation mediated by interleukin-1. N Engl J Med. 2000;343(10):732-4.
18. Isoda K, Ohsuzu F. The effect of interleukin-1 receptor antagonist on arteries and cholesterol metabolism. J Atheroscler Thromb. 2006;13(1):21-30.
19. Watanabe N, Kobayashi Y. Selective release of a processed form of interleukin 1 alpha. Cytokine. 1994;6(6):597-601.
20.Kasper, Braunwald. Harrison textbook of internal medicin. 2008; 4:342-345.
21. Tedgui A, Mallat Z. Cytokines in atherosclerosis: pathogenic and regulatory pathways. Physiol Rev. 2006;86(2):515-81.
22. Longhurst JC, Tjen ALSC, Fu LW. Cardiac sympathetic afferent activation provoked by myocardial ischemia and reperfusion. Mechanisms and reflexes. Ann N Y Acad Sci. 2001;940:74-95.
Files
IssueVol 3, No 4 (2020) QRcode
SectionOriginal Article
DOI https://doi.org/10.18502/igj.v3i4.7461
Keywords
Atherosclerosis Interleukin-1 Unstable Angina Myocardial Infarction with Q Wave and Non Q Wave
Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
1.
Khazaei HA, Bolouri A, Harati H, Mohammadi M, Nasiraldin Tabatabei SM, Khazaei A, Pishjuo M, Ayoubi Yazdi Z, Khazaei B. Evaluation of Serum Level of Interleukin-1 in Patients Suffering from Acute Coronary Syndrome, Admitted to the CCU Ward of Amir-Almomenin Hospital of Zahedan. Immunol Genet J. 2020;3(4):222-227.